BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8017846)

  • 1. Activation in vitro of peritoneal macrophages by a nocardia fraction.
    Ben-Efraim S; Rashid G; Gittel H; Tax C; Ciorbaru RB
    Anticancer Res; 1994; 14(2A):449-52. PubMed ID: 8017846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
    Rashid G; Gittel H; Ben-Efraim S
    Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
    Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
    Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-alpha, PGE2 and nitrite, in vitro studies.
    Ben-Efraim S; Tak C; Fieren MJ; Romijn JC; Beckmann I; Bonta IL
    Immunol Lett; 1993 Jul; 37(1):27-33. PubMed ID: 8225404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of macrophages and cytokines into rejection mechanism of the drug-resistant and immunogenic murine lymphoma P388/adria.
    Kisseleva E; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1996; 16(4A):1971-8. PubMed ID: 8712729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages.
    Chen BC; Hsieh SL; Lin WW
    J Leukoc Biol; 2001 Feb; 69(2):280-8. PubMed ID: 11272279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
    Sato K; Tomioka H; Saito H
    Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.
    Kirikae T; Ojima I; Ma Z; Kirikae F; Hirai Y; Nakano M
    Biochem Biophys Res Commun; 1998 Apr; 245(3):698-704. PubMed ID: 9588177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation by polysaccharide biological response modifier isolated from Aloe vera L. var. chinensis (Haw.) Berg.
    Liu C; Leung MY; Koon JC; Zhu LF; Hui YZ; Yu B; Fung KP
    Int Immunopharmacol; 2006 Nov; 6(11):1634-41. PubMed ID: 16979117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tumor necrosis factor alpha in murine macrophages with various strains of Coxiella burnetii and their lipopolysaccharides.
    Kubes M; Kuzmová Z; Gajdosová E; Ihnatko R; Mucha V; Toman R; Kovácová E
    Acta Virol; 2006; 50(2):93-9. PubMed ID: 16808326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional analysis of murine resident and induced peritoneal macrophages.
    Turchyn LR; Baginski TJ; Renkiewicz RR; Lesch CA; Mobley JL
    Comp Med; 2007 Dec; 57(6):574-80. PubMed ID: 18246870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate inhibits LPS-induced tumor necrosis factor production in vivo.
    Durez P; Appelboom T; Vray B; Pira C; Goldman M
    Eur Cytokine Netw; 1998 Dec; 9(4):669-72. PubMed ID: 9889412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory activities of Nocardia opaca.
    Tomecki JK; Cieślik K; Kordowiak AM; Barot R
    Acta Microbiol Pol; 1993; 42(2):151-6. PubMed ID: 7509560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of tumor necrosis factor alpha by resident peritoneal cells of mice.
    Błach-Olszewska Z; Juszczyk M; Zaczyńska E
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):63-6. PubMed ID: 8239910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G; Korzets Z; Bernheim J
    Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multinutrient undernutrition dysregulates the resident macrophage proinflammatory cytokine network, nuclear factor-kappaB activation, and nitric oxide production.
    Anstead GM; Chandrasekar B; Zhang Q; Melby PC
    J Leukoc Biol; 2003 Dec; 74(6):982-91. PubMed ID: 12960263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis.
    Fieren MW; van den Bemd GJ; Bonta IL; Ben-Efraim S
    J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.